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Abstract
To be able to analyze the relationship between the level of resistance and the use of antimi-
crobials, it is necessary to collect detailed data on antimicrobial usage. For this reason, data
on antimicrobial use on 495 pig farms from entire Germany were collected and analyzed. In
Germany, each application and dispensing of medicines to food-producing animals is docu-
mented in detail obligatorily by the veterinarian. This information was collected retrospec-
tively for the year 2011. The analyses undertook separate examinations on the age groups
sow, piglet, weaner and fattening pig; both the route of administration and indication per ac-
tive ingredient, and active ingredient class, were evaluated. In total, 20,374 kg of antimicro-
bial substances were used in the study population. Tetracyclines were used in highest
amounts, followed by beta-lactams, trimethoprim-sulfonamides and macrolides. Concern-
ing the frequency of using an active substance per animal, polypeptides were most com-
monly administered. In all age groups, respiratory infections were the main indication for
using antimicrobials, followed by intestinal diseases in piglets, weaners and fattening pigs
and diseases of reproductive organs in sows. Over a period of 100 days, the median num-
ber of treatment days with one antimicrobial substance for piglets was 15 days, for weaners
about 6 days, for fattening pigs about 4 days and for sows about 1 day. A multifactorial
ANOVA was conducted to investigate which factors are associated with the treatment fre-
quency. The factors “veterinarian” and “age group” were related to the treatment frequency,
just as the interaction between “veterinarian” and “farm size” as well as the interaction be-
tween “veterinarian” and “age group”.
Introduction
The availability of antibiotics for treating bacterial diseases in animals must be preserved to en-
sure animal health and welfare. As any use of antimicrobial substances may be associated with
the development of resistance [1], the wide distribution of antimicrobial resistance has become
an increasing problem in human and veterinary medicine [2]. To limit further spread, actions
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were already taken in veterinary medicine. As an example, the use of antibiotics for growth
promotion was banned in the European Union in 2006 (Regulation (EC) No. 1831/2003) [3].
To be able to assess the relationship between the observed resistance and the use of antimi-
crobials, it is necessary to provide detailed data on antimicrobial usage. In the Zoonoses Direc-
tive 2003/99/EC of the European Commission [4], the monitoring of antimicrobial resistance
in zoonotic agents and other bacteria, which might be of relevance for public health in the
Member States of the European Union is made mandatory. In contrast to this, up to now no
legal requirements for the collection of data on consumption of antimicrobials has been imple-
mented on EU level. Recently, European Medicines Agency (EMA) has published a reflection
paper on how to collect data on consumption of antimicrobial agents in animals [5].
Years ago, active monitoring programs on antimicrobial consumption were established in
some European countries, which have been continuously carried out to date (see e.g. [6–9]). In
all of these monitoring systems data on antibiotic consumption are collected from pharmacies,
wholesalers, and the pharmaceutical industry. However, these approaches only provide valu-
able data if prescription of the drugs to the different livestock populations is recorded. In Ger-
many, veterinarians have the right to dispense. German veterinarians are allowed to obtain
drugs by wholesalers and pharmaceutical companies, to deliver drugs to the animal owners
and to produce and keep drugs. In addition, for each treatment in animals the veterinarian has
to take the responsibility for. This has to be documented formally by means of the German
pharmaceutical law [10]. As the regulations regarding the sale and delivery of antimicrobial
drugs in Germany basically differ from those of other EUMember States, the concepts already
established there cannot be applied for Germany due to the non-central federal state system
and the right of veterinarians to sell drugs. Therefore, it is necessary to develop new concepts
for appropriate data collection in Germany. Thus, developing a bottom-up approach for the
detection of antimicrobials in animals was one of the goals formulated several times in the Ger-
man Antibiotics Resistance Strategy [11]. This should be an important contribution to
public health.
For this reason a feasibility study was conducted successfully in the years 2007 and 2008
and a method for collecting data on consumption of antimicrobials in farm animals was devel-
oped [12,13]. The aim of this recent study was to run a follow-up cross-sectional investigation.
Emphasis was laid on collecting data from a representative subset of the major animal livestock
populations to achieve a representative picture on antimicrobial usage in Germany.
Material and Methods
1. Study Design
The study was set up as a cross-sectional study, based on voluntary participation of veterinari-
ans and farmers. To ensure the representativeness for the whole of Germany, an appropriate
sampling plan was created. In a first step, Germany was classified in four regions: Northwest,
Middle, East and South, already defined by Merle et al. [14]. These regions were defined on the
basis of their agricultural structures. Region “East” is marked by relatively few huge farms. In
contrast, region “South” is characterized by many small farms. In region “Northwest”, there is
a high density of livestock, in region “Middle” only a moderate density of livestock is present.
In a second step, districts, which are typical for these regions, were identified with regard to an
average number of livestock in the region. From these districts participants were recruited. All
participants were informed of the study's aim and gave written consent for data to be used for
research purposes. The study is addressing data, which were taken from the forms, on which
treatments of animals and the delivery of animal drugs to animal owners are documented by
the veterinarian. With these forms each application and dispensing of medicines to food-
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producing animals by the veterinarian is documented obligatorily in Germany. Our study
based on official forms, on which any treatment administered to the animal is documented by
the veterinarian. Because these documents have to be filled in obligatory, naturally no illegal
treatments are noted on these. It should be stressed here in addition that prophylactic usage of
antibiotics is not allowed in Germany. German veterinarians adhere to special guidelines on
the prudent use of antibiotics in veterinary medicine [1,15].
All participants gave consent to use the data for this study, given that all data of pig holding
farmer and veterinarian were pseudonymized before the data were analyzed. This was stated in
a privacy statement with each participant. The study protocol was approved by the sponsor
(the Federal Institute of Risk Assessment) and announced to the data protection officers of
both universities.
The recruitment of participants and input of their data was carried out in the period from
May 2012 until February 2013. Data were collected retrospectively for the calendar year 2011.
2. Data collection and analysis
The data collection was implemented following the concepts from the feasibility study in 2007/
2008 [13]. Data were taken from the forms, on which treatments of animals and the delivery of
animal drugs to animal owners are documented by the veterinarian. With these forms each ap-
plication and dispensing of medicines to food-producing animals by the veterinarian is docu-
mented obligatorily in Germany. Basic information of these documents are treatment or
delivery date, the name of veterinarian and farmer, number, type and identity of the animals to
be treated, diagnosis, drug name, amount of applied or submitted drug, charge number, dosage
per kg per day as well as type and duration of administration and the withdrawal period.
In addition, an animal-specific questionnaire was sent to participating farmers, who should
give information about farm management, keeping of animals, and also the number of animals
kept as well as livestock places.
The data were entered manually into a database developed during the feasibility study—
here the Open-Source relational database system MySQL was used in its current version (cur-
rently 5.0. 51a). There were mandatory fields defined in the input mask, which complied with
the mandatory information on the treatment and delivery form. To enable fast manual entering
of data, drop-down lists were applied. Diagnosis was linked to eight predetermined diagnostic
groups (udder disease, skin disease, respiratory disease, intestinal disease, central nervous sys-
tem disease, joint disease, reproductive organs and other diseases). One entered data record
corresponded to one treatment. All data records were checked for completeness and pharma-
cological plausibility, both during data entry as well as during a final extensive plausibility
checkup, taking into account information stated in the additional farmer's
questionnaire received.
In the context of the analysis, each age group, defined by weight and production system was
considered separately. Thus, the four age groups piglet (4 kg on average), weaner (15 kg on av-
erage), fattening pig (50 kg on average) and sow (200 kg on average) were distinguished. Allo-
cation to these groups was done to the best extent possible on the basis of the information
documented on the identity of the animals treated or the type of pigs kept on the farm. It was
assumed that a sow is housed for more than one year, so the time period under risk of a sow
was stated as one year. A piglet is suckled 28 days on average before it is transferred to the next
production phase. In Germany the average production phase of a weaner is about 46 days.
With a service period of about seven days between groups, this yields approximately 6.89 pas-
sages for weaning units per farm per year. In Germany, a fattening pig is fattened 115 days on
average. With a subsequent time-window for cleaning and disinfection of 14 days, 2.83
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fattening passages arise per year and per farm on average [16]. Considering these average val-
ues the reporting of the antimicrobial use within the different age groups refers to one
production period.
In the context of the analysis, the participating pig farms were divided into various farm size
groups based on the numbers of livestock places per farm. To achieve this, the farm size groups
“small”, “medium” and “large” were defined for each age group on the basis of tertiles derived
from our data. Medium-sized farms were defined as those with 80 to 199 sows, 820 to 2,049
piglets, 330 to 799 weaners and 370 to 999 fattening pigs.
The analysis involved the determining of the used active ingredients included in the drug
applied and active ingredient quantities per age group. Focus of the analysis was laid on the cal-
culation of amounts of antimicrobial substances and as well on the calculation of number of
treatments per active ingredient and animal (treatment unit or number of used daily doses
(nUDD)), and the calculation of treatment days per active ingredient per animal (treatment
frequency). A treatment unit (UDD) is equivalent to the administration of one active ingredi-
ent to one animal on one day [13,17]. Based on this, the sum of all treatment units (nUDDs) in
an observed population over an observation period can be calculated as follows:
nUDDðnumber of used daily dosesÞ
¼ number of treated animals number of treatment days number of active ingredients
The treatment frequency specifies how many days an animal in a herd is treated with one
active ingredient on average [13,17]. The treatment frequency (TF) is calculated using:
TF ¼ nUDD
population size
To calculate the treatment frequency for each farm per year, the number of animals kept per
farm per year had to be determined. For this purpose, the livestock places per farm and age
group were multiplied by the average number of production periods per farm per year (sow = 1;
weaner = 6.89; fattening pig = 2.83). The number of piglets per farm and year was always esti-
mated for any one farm keeping sows, by multiplying the number of sows on this farm by the
average number of litters per sow and year (2.35) and the average number of weaned piglets per
sow and litter (10.25).
In the course of the analysis, also factors were analyzed which were assumed to have an in-
fluence on the treatment frequency. These factors were analyzed for each age group separately
via a multifactorial analysis of variance (ANOVA, target variable: logarithmized treatment fre-
quency, standardized per 100 days of animals kept). Region and farm size were examined as
fixed factors; the responsible veterinarian was examined as random factor. For model selection
backward selection procedures were used.
Statistical analyses were performed using SAS, version 9.3 TS level 1M2 (SAS Institute Inc.,
Cary, NC, United States).
Results
1. Study Population
In total, 18,151 data records of 495 pig farms from entire Germany were collected and ana-
lyzed. On the 495 participating pig farms, one or several age groups were kept, giving a total of
945 groups (sow, piglet, weaner, fattening pig). These groups were allocated as follows: 215
farms keeping sows, 199 farms keeping piglets, 187 farms keeping weaners, as well as 344 farms
keeping fattening pigs. In relation to the entire German pork production the study covered
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2.19% of all livestock places for sows, 6.14% for piglets, 3.17% for weaners and 2.85% for fatten-
ing pigs in Germany (data source from Federal Statistical Office [18]).
The analysis of the data was carried out in two different ways. On the one hand, the amount
of antimicrobial agents consumed was determined separately for the different age groups. This
was reported with consideration of the season, the administration route and the indication. On
the other hand, the frequency of treatments was analyzed separately according to age group.
2. Used quantities
In total, 20,373.6 kg of antimicrobial agents were used on the study farms in 2011. Tetracyclines
were most commonly used with a consumption quantity of 7,275.5 kg (35.7%), followed by
beta-lactams with 6,720.9 kg (33.0%), potentiated sulfonamides (trimethoprim-sulfonamides)
with 2,126.6 kg (10.4%) and macrolides with 2,827.7 kg (13.9%). Polypeptides (858.4 kg, 4.2%)
and aminoglycosides (248.2 kg, 1.2%) were in the fifth and sixth position regarding consump-
tion quantities. The consumption quantities per active ingredient were also evaluated separately
for each age group. In addition, seasonal variations in the consumption of certain antimicrobial
substances were examined according to the age group (Table 1).
Among the sows, the active ingredients of trimethoprim-sulfonamides, tetracycline and
amoxicillin were administered most. Tetracycline was used the most in spring. The consump-
tion amount of tetracycline in the spring was about five-fold higher than the amount consumed
in the other seasons. The highest amounts of trimethoprim-sulfonamides were consumed in
autumn, and almost as much in summer. Amoxicillin was used in summer in highest amounts,
but the least in autumn. The highest drug use for all active ingredients was detected in spring.
Among piglets, amoxicillin, tetracycline, trimethoprim-sulfonamides and colistin were used
in highest amounts, also with seasonal differences. In contrast to the fattening pigs, amoxicillin
was least consumed in winter, with a steady increase in consumption amounts from spring to
autumn. Amoxicillin was used more than twice as much in autumn than it was in winter. This
observation was also made for tetracycline, but with the lowest consumption level being in
spring. For all active ingredients, the highest drug use in piglets was detected in autumn.
Among weaners, amoxicillin, tetracycline, chlortetracycline, and about equal proportions of
trimethoprim-sulfonamides and colistin were used in highest amounts. In this age group, sea-
sonal differences in regard to the consumed quantities of several active ingredients were also
observed. Amoxicillin was consumed the most in spring, twice as much as in summer, with a
steady rise in the consumption quantities from summer to spring. Distributed over the year,
tetracycline as well as trimethoprim-sulfonamides were consumed constantly. However, the
amounts of chlortetracycline were much higher in spring than in the second half of the year. In
weaners, colistin was used the least in autumn, but rather constantly over the rest of the year.
For all active ingredients, the highest drug use in weaners was detected in spring.
Amoxicillin, tetracycline, tylosin and chlortetracycline were used in highest amounts in fat-
tening pigs and there were different seasonal patterns. Amoxicillin was more often used in win-
ter than in the summer months, whereas the active ingredient tylosin was used about 100 kg
less in winter than in the summer. For all active ingredients, the highest drug use for fattening
pigs was detected from June to August, the lowest use in autumn.
From all 20,373.6 kg antimicrobial substances used, 19,903 kg (98%) were administered
orally, and only 472.3 kg (2%) were administered per injection. However, looking at the data
records, there were more than twice as many records on parenteral administration than on oral
administration. Among the four age groups, especially for sows there were mainly records on
treatment per injection. Regarding the fattening pigs, records on parenteral and oral treatments
were approximately the same, with slightly more records on parenteral treatments. In contrast,
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for weaners records on oral administration were about twice as frequently as records on paren-
teral treatments. Among the piglets, there were more records on parenteral treatments than for
oral administration.
In the course of the analysis, also the consumption amounts of antibiotic active substances
according to several indications were determined for the different age groups (Table 2).
In piglets, the highest amounts of antimicrobial substances were used against respiratory
diseases. In second and third place, "other diseases" and "intestinal diseases" were documented
as reasons for treatment. Respiratory diseases in piglets were first and foremost treated with
amoxicillin, but also with tetracycline. Intestinal diseases in piglets were mostly treated with co-
listin and tylosin.
Also in sows, the highest quantities of antimicrobial active ingredients were used against re-
spiratory diseases. “Other diseases” were in second place, too, but in third place were diseases
of the reproductive organs. Respiratory diseases in sows were particularly treated with tetracy-
cline but also with amoxicillin. Diseases of the reproductive organs were mainly treated with
amounts of tetracycline.
Table 1. Seasonal effects regarding consumed quantities taking the example of selected used active ingredients in highest amounts.
active ingredient Consumed quantities in kg
spring summer autumn winter total
sow
Amoxicillin 66.9 75.4 23.6 54.7 220.5
Chlortetracycline 23.2 27.5 26.1 21.0 97.9
Colistin 2.4 1.4 1.5 1.0 6.3
Sulfadiazine 237.6 97.2 295.2 216.0 846.0
Tetracycline 592.3 134.9 100.0 118.3 945.5
Tylosin 2.6 11.3 3.6 1.0 18.5
piglet
Amoxicillin 304.8 446.8 452.4 200.5 1,404.6
Chlortetracycline 38.4 36.2 62.9 16.7 154.2
Colistin 40.9 68.7 60.7 36.9 207.2
Sulfadiazine 113.4 75.8 132.1 56.9 378.2
Tetracycline 116.7 180.2 220.6 133.5 651.0
Tylosin 40.3 21.9 19.3 21.7 103.1
Weaner
Amoxicillin 907.2 480.9 547.8 753.6 2,689.5
Chlortetracycline 228.0 182.0 108.1 129.6 647.7
Colistin 164.4 136.0 77.5 151.1 528.9
Sulfadiazine 153.6 134.4 111.4 187.6 587.0
Tetracycline 385.2 268.4 304.2 334.0 1,291.9
Tylosin 36.9 34.8 26.4 35.3 133.4
fattening pig
Amoxicillin 574.2 505.8 535.9 652.7 2,268.6
Chlortetracycline 361.1 327.0 326.3 413.5 1,427.8
Colistin 42.0 21.3 26.7 25.8 115.9
Sulfadiazine 91.4 107.4 173.5 104.8 477.2
Tetracycline 302.2 364.5 199.9 240.1 1,106.6
Tylosin 483.8 485.4 474.6 383.8 1,827.7
doi:10.1371/journal.pone.0119114.t001
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In fattening pigs and weaners, the highest quantities of antimicrobial substances were also
used against respiratory diseases.
As in piglets, respiratory diseases in weaners were mainly treated with amoxicillin, but also
with tetracycline. Intestinal diseases were especially treated with colistin, but also tetracycline
and tylosin were used in approximately equal amounts.
Also in fattening pigs respiratory diseases were mainly treated with amoxicillin. In addition
to amoxicillin, especially chlortetracycline played an important role in the treatment of respira-
tory diseases. The treatment of intestinal diseases was primarily carried out with tylosin.
3. Treatment units
The amount of drugs applied is strongly influenced by the recommended dosage as well as the
body weight of the treated animal group. Therefore, tons of used drugs may only give a rough
picture of the situation. Thus, treatment units were calculated. To illustrate the difference be-
tween these two ways of analyses, the Figs. 1–4 show the used treatment units compared to the
Table 2. Amounts of active ingredients per age group and indication group (selected active ingredients).

















Amoxicillin 125.8 1.0 8.5 0.8 73.8 - 10.6 220.5
Chlortetracycline 41.1 - - <0.1 21.5 - 35.3 97.9
Colistin 0.5 5.7 - - 0.1 - <0.1 6.3
Sulfadiazine 39.6 - - - 768.0 - 38.4 846.0
Tetracycline 776.2 4.6 - - 89.6 - 75.1 945.5
Tylosin 1.1 12.5 0.9 - 2.7 <0.1 1.3 18.5
piglet
Amoxicillin 849.1 12.2 13.9 14.5 514.9 - - 1404.6
Chlortetracycline 149.3 4.0 - - 0.9 - - 154.2
Colistin 2.1 200.4 - - 4.6 - - 207.2
Sulfadiazine 281.3 74.3 - 4.8 17.80 - - 378.2
Tetracycline 571.5 - - - 79.5 - - 651.0
Tylosin 6.8 88.1 - - 8.3 - - 103.1
weaner
Amoxicillin 2195.3 52.5 1.3 37.1 403.3 - - 2689.5
Chlortetracycline 635.9 1.4 - - 10.4 - - 647.7
Colistin 5.3 520.4 - - 3.2 - - 528.9
Sulfadiazine 518.2 50.4 - 6.4 12.0 - - 587.0
Tetracycline 1068.1 127.3 - - 96.6 - - 1291.9
Tylosin 5.1 112.2 - - 16.1 - - 133.4
fattening pig
Amoxicillin 1924.0 92.7 14.1 6.3 231.5 - - 2268.6
Chlortetracycline 1175.7 181.6 - 2.8 67.7 - - 1427.8
Colistin 6.4 95.2 - - 14.5 - - 116.1
Sulfadiazine 413.9 26.0 - - 37.2 - - 477.2
Tetracycline 830.9 103.3 - 2.8 169.6 - - 1106.6
Tylosin 39.9 1747.3 0.1 - 46.1 - - 1833.4
doi:10.1371/journal.pone.0119114.t002
Antibiotic Usage in Pigs in Germany
PLOS ONE | DOI:10.1371/journal.pone.0119114 March 18, 2015 7 / 28
used quantities per age group. The great difference between the consumed quantity and the
number of treatment units of some active ingredient classes is due to the different dosages of
the active ingredients.
In sows, tetracyclines, trimethoprim-sulfonamides and beta-lactams are up front in terms of
treatment units as well as the consumed quantities. It is remarkable that fluoroquinolones,
which were only used in small quantities, are in fourth place, concerning the treatment units.
Also macrolides, polypeptides and pleuromutilins take a relatively large proportion of the treat-
ments in this age group.
In piglets, beta-lactams, tetracyclines and trimethoprim-sulfonamides were most commonly
used in terms of quantity. Regarding the treatment units, polypeptides became more promi-
nently used in contrast to the use of tetracyclines. Macrolides, which only are in fifth place in
terms of quantity, were nearly used as often as tetracyclines. Only small quantities of aminogly-
cosides, fluoroquinolones and cephalosporins were used, but they accounted for a relatively
large proportion of treatment units.
Among weaners, there are clear differences between consumed quantities and treatment
units of each active ingredient class. In terms of quantity, especially beta-lactams, tetracyclines
and trimethoprim-sulfonamides were used. Nonetheless, looking at treatment units, polypep-
tides were the most used antimicrobial class in this age group, followed by beta-lactams
and tetracyclines.
Fig 1. Used quantities and treatment units of applied classes of active ingredients for sows.
doi:10.1371/journal.pone.0119114.g001
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In fattening pigs, tetracyclines were most commonly used with regard to the consumed
quantities, followed by beta-lactams and macrolides. On the treatment unit scale, macrolides
were ahead of beta-lactams. When directly comparing the consumed quantities and treatment
unit scale, the total amount of used polypeptides was comparatively low, but the number of
treatment units was higher. It becomes obvious that polypeptides and pleuromutilins are much
more important as is shown when looking at the consumed quantities only.
4. Treatment frequencies
Looking at the treatment frequencies depicted as distribution of the farm specific treatment fre-
quencies with regard to one year and one passage, respectively, it was calculated that a sow on a
typical farm was treated with one active ingredient on 3.2 days (median) per year on average. A
fattening pig was treated with one active ingredient on 4.2 (median) days in its 115-day fatten-
ing period, with a combination of two active ingredients on 2.1 days. In its 46-day production
period, a weaner was treated with one active ingredient on 3.1 (median) days, with a combina-
tion of two active substances on about 1.5 days. Within its four-week suckling period, a piglet
received treatment with one active ingredient on 4.1 (median) days.
Fig 2. Used quantities and treatment units of applied classes of active ingredients for piglets.
doi:10.1371/journal.pone.0119114.g002
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In the following, the treatment frequencies with one active ingredient per farm and 100
days, given as median value of all farms, are described, to ensure the comparability between the
age groups. Converted to 100 days, a median treatment frequency of 0.86 days arose for sows,
14.74 days for piglets, 6.62 days for weaners and 3.67 days for fattening pigs.
The Figs. 5–8 show that the treatment frequencies across the farms are skewed to the right,
in all age groups without exception. Therefore, the distribution is described with robust statisti-
cal measures only (Table 3). The comparison of all age groups shows that piglets were treated
the most frequent and sows were treated the least.
In the course of the analysis, standardized therapy frequencies of individual active ingredi-
ent classes were calculated for the different age groups (Table 4). Within all age groups, beta-
lactams represent the active ingredient class that was used on most farms. Thus, beta-lactams
were used for treating sows on 167 farms (78% of all sow keeping farms), for treating piglets on
170 farms (85% of all piglet keeping farms), for treating weaners on 135 farms (92% of all
weaner keeping farms) and on 260 farms for treating fattening pigs (76% of all farms keeping
fattening pigs). Therefore, over a period of 100 days, a piglet was treated at about 4 days with
beta-lactams (within the farms in which beta-lactams were applied). Furthermore, beta-lactams
Fig 3. Used quantities and treatment units of applied classes of active ingredients for weaners.
doi:10.1371/journal.pone.0119114.g003
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were used in sows at not even one day (0.2), weaners at about two days and fattening pigs at
about one day (0.8).
As another example, polypeptides, which were used on 110 piglet keeping farms (55% of all
farms keeping piglets) for treating piglets, were applied at about 10 days on these farms over a
period of 100 days. In contrast, polypeptides were only used on 7 sow keeping farms (3% of all
sow keeping farms). Within these farms, polypeptides were applied at 2.2 days to sows, but all
in all they were not important for treating sows. Furthermore, polypeptides were used in 55%
of all weaner keeping farms but only on 18% of all farms keeping fattening pigs. Within these
farms, weaners were treated at about 5 days with polypeptides and fattening pigs at 1.8 days
over a period of 100 days.
To investigate which factors are associated with the treatment frequency in general, a multi-
factorial ANOVA was conducted for each age group separately. In Table 5 the geometric
means of the 100-day-treatment frequency of the fixed influence factors (region and farm size)
for the different age groups are shown. These factors are suggesting effects for region and farm
size on the uni-factorial level.
Following the ANOVA-multi-factorial approach:
neither “region” nor “farm size” had a significant impact on the treatment frequency; except
for weaners, where these two fixed factors seemed to have a slight influence (Table 6). Further-
more, it can be noted that the “veterinarian” as well as the interaction between “veterinarian”
and “farm size” (except for sows) showed a statistically significant association on the 5%-level.
This may indicate the direct relationship of farmers and veterinarians, who specialize in pig
Fig 4. Used quantities and treatment units of applied classes of active ingredients for fattening pigs.
doi:10.1371/journal.pone.0119114.g004
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farming. Using this model, in general a substantial amount of the variance of the treatment fre-
quency for sows could be explained at 33%, for piglets at 50%, for weaners at 45% and for fat-
tening pigs at 27%.
Discussion
1. General study design
Data presented here was created in the setting of a cross-sectional study taken into account the
variability in German farming practice. Therefore a stratified approach was used with four re-
gions of different agricultural areas. The formal study base used was the official forms of re-
cording the use of pharmaceutical drugs which are obligatory by law in Germany. Therefore all
calculations were based on individual application data on farm level, including the drug, the
amount, the number of days, the number of animals treated, and the animal age group respec-
tively on an individual level of treatment. This concept is in contrast to other (monitoring)
studies, where mostly the entire amount per farm or even more general groups was recorded
and numbers of animals treated and other variables of interest have to be estimated from this
aggregated information (see e.g. studies in Denmark [6] or the Netherlands [7]). This investiga-
tion was conducted as a follow-up of the study implemented by Merle et al. [13], where the
general feasibility of the concept was proofed. The study was set up as a cross-sectional study
Fig 5. Distribution of treatment frequencies of sows.
doi:10.1371/journal.pone.0119114.g005
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with representative sampling using recorded information from veterinarians and farmers on
the application of antibiotics for the year 2011.
As sales data do not contain any information on the usage of the drugs, it is not possible to
combine sales data with real antibiotic application for animals. Bondt et al. [19] and Chauvin
et al. [20] also stated that this is inadequate. Therefore, Bondt et al. [19] propose collecting de-
tailed data to enable an assessment on the real antimicrobial usage. In our study this was imple-
mented by using the detailed and informative data of the treatment and delivery forms. These
documents allow an evaluation of antimicrobial usage on the level of individual treatment. Fur-
thermore, they allow a categorization of treatments by the individual age groups, which was
also considered by Bondt et al. [19]. Thus, on the basis of the used data, we were able to evalu-
ate the consumed quantities and the treatment frequencies for piglets and sows separately from
each other. This is a denotative benefit compared to the evaluation of other monitoring pro-
grams [6,7], in which sows and piglets are considered as one unit.
2. Study population
This study is based upon voluntary participation of farmers and veterinarians. It has to be
taken into account that especially those veterinarians and farmers may be open to participa-
tion, who usually care about a diligent and thoughtful handling of drugs and who are seeking
Fig 6. Distribution of treatment frequencies of piglets.
doi:10.1371/journal.pone.0119114.g006
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to improve their management. Thus, it is possible that the real use of antimicrobial substances
is higher and a selection bias cannot be completely ruled out. To ensure compliance with the
study, all information was pseudo-anonymized and no information was transferred to veteri-
nary authorities. This resulted in a study base of farms, which is closely connected to the figures
known from the demographic structures in pig-holdings farms in Germany concerning the re-
gional distribution as well as the structures of farming sizes and general facilities. Therefore,
the coverage of livestock places in the study population compared to the total livestock popula-
tion in Germany is sufficiently high. These figures were evaluated on the basis of the annual
German livestock microcensus (Federal Statistical Office, microcensus 2011). In addition these
results show a huge variety of treatment frequencies per farm with some extended results (e.g.
a farm with a treatment frequency within the 42 day flat-deck period of approximately 75, i.e. a
treatment with two active ingredients per day for all animals). This should be seen as an argu-
ment that a severe selection bias is not present in the data.
3. General measurement of antibiotics use
For evaluating and describing the antimicrobial usage, various definitions and variables have
been introduced over time [17,21,22]. Until now, no standardized variables have been
Fig 7. Distribution of treatment frequencies of weaners.
doi:10.1371/journal.pone.0119114.g007
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established which enable an assessment of the antimicrobial use between different countries.
This is basically due to an enormous spread of study designs and data structures linked to dif-
ferent structures in different countries. But, the examination of used quantities on its own al-
lows a general overview of the situation, which is performed by the ESVAC project [5,23,24].
However, active ingredients, which were applied at a high dosage over several days, carry
higher weight than those which were applied at a lower dosage. In addition, the frequency of
application may be different, depending on the type of drug used and whether they maintain
the effect of the active ingredient for a longer time. This may lead to an overvaluation or under-
valuation of the situation [25]. Therefore, a comparison between the consumed quantities per
active ingredient class and the number of treatment units allows a more differentiated view on
the importance of the individual active ingredient classes.
Using an appropriate variable is essential for interpreting the antibiotic usage [26]. In addi-
tion, terms were already defined by various authors, which link the used quantity to a specific
time period or a definite population. For example, Callens et al. [26] and Vieira et al. [27] apply
the so-called “treatment incidence” for describing the antimicrobial use in detail and for com-
paring the antimicrobial use between farms in a standardized way. For the same reason, Dun-
lop et al. [28] use the "treatment rate", and van der Fels-Klerx et al. [29] use the NDD (number
of daily dosages per average pig year). Although all these terms have the same background,
Fig 8. Distribution of treatment frequencies of fattening pigs.
doi:10.1371/journal.pone.0119114.g008
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namely the representation of the actual treatments and with it the actual situation, all terms are
defined and calculated slightly differently and thus are only conditionally comparable with
each other. Therefore, a standardization is necessary [25].
In the context of the analysis presented here, the antibiotic use was examined regarding the
used quantities as well as the frequency of treatments. To do this, the variables "treatment unit"
and especially "treatment frequency" were used. This term specifies the average number of days
an animal of a defined population is treated with one active ingredient within a certain period
of time. The treatment frequency does not distinguish between dosages, but it merely indicates
how often an animal is treated with one active ingredient. Therefore, low and high dosed active
ingredients, as well as treatment of young or elder animals, are equally weighted, unlike pure
consumption quantities or terms which are based on dosages and standardized body weights
(Jensen et al. [22]). On that account, the treatment frequency is only limited comparable with
the DDDAkg, which is established in Denmark [6], or the DDDkg, which is established in the
Netherlands [7].
Whereas the concept in general is comparable to the nDDDA (number of defined daily
doses animal; see ESVAC [5]), the main difference is that our calculation is based on detailed
knowledge of the number of used applications. In contrast, the number of DDDAs proposed
by ESVAC is calculated on the basis of amounts used and dosages assumed for standard
weighted animals used, which therefore may be interpreted as an estimator of the treatment
frequency used here.
The treatment frequency is comparable between years and regions, and may also refer to an
arbitrary population [13]. For calculating the treatment frequency, detailed information about
the individual application as well as the population size is needed. Furthermore, if appropriate
data are collected, the treatment frequency can also be calculated for each active ingredient sep-
arately. This was done by Vieira et al. [27] in a similar manner by using ingredient-related
treatment incidence rates.
4. Amounts of antimicrobial drug consumption and sales data
In general, among all age groups in pigs the highest amounts of antimicrobials used were tetra-
cyclines, followed by beta-lactams and trimethoprim-sulfonamides. Also in regard to the sales
data for all animals species in Germany, tetracyclines and beta-lactams are in first and second
place, followed by trimethoprim-sulfonamides, macrolides and polypeptides [23,30].
In the feasibility study of the years 2007/2008, Merle et al. [31] also asserted that tetracy-
clines were quantitatively most commonly used on pig farms in Germany. This active ingredi-
ent class was followed by trimethoprim-sulfonamides and macrolides. Beta-lactams, which
were in second place regarding consumed quantities in our study, only ranked fourth in the
feasibility study.
Table 3. Distribution of the 100-day-treatment frequency per farm for the four different age groups.
age group treatment frequency per 100 days
n min P5 P25 median P75 P95 max
sow 215 0.005 0.023 0.26 0.86 2.39 13.32 26.43
piglet 199 0.006 0.593 4.78 14.74 35.71 93.65 261.86
weaner 187 0.011 0.126 2.20 6.62 17.75 45.50 180.80
fattening pig 344 0 0.031 0.92 3.67 7.84 19.09 45.62
doi:10.1371/journal.pone.0119114.t003
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Table 4. Distribution of the 100-day-treatment frequency per farm and active ingredient class for the four different age groups.
active ingredient class Treatment frequency per 100 days
n min P5 P25 median P75 P95 max
sow
Beta-lactams 167 0.003 0.020 0.05 0.17 0.51 1.69 12.47
Aminoglycosides 65 0.001 0.005 0.02 0.06 0.26 1.08 1.62
Cephalosporins 71 0.003 0.005 0.02 0.04 0.11 0.51 1.38
Tetracyclines 81 0.002 0.004 0.10 0.39 1.89 8.32 9.55
Polypeptides 7 0.064 0.064 0.95 2.23 7.56 11.34 11.34
Fluoroquinolones 111 0.002 0.011 0.04 0.15 0.42 1.28 3.17
Lincosamides 21 0.003 0.007 0.02 0.07 0.13 0.46 1.47
Pleuromutilins 12 0.003 0.003 0.07 0.26 0.78 3.65 3.65
Makrolides 55 0.002 0.002 0.02 0.05 0.19 1.44 10.58
Trimethoprim-sulfonamides 77 0.003 0.020 0.09 0.26 1.87 17.06 21.19
Fenicoles 17 0.002 0.002 0.01 0.02 0.04 0.27 0.27
Sulfonamides . . . . . . . .
piglet
Beta-lactams 170 0.006 0.153 1.11 4.33 10.06 28.86 58.97
Aminoglycosides 103 0.011 0.067 0.33 1.15 3.21 8.81 28.05
Cephalosporins 44 0.015 0.045 0.18 0.56 2.30 6.03 11.86
Tetracyclines 107 0.010 0.114 1.35 3.46 8.82 25.94 49.92
Polypeptides 110 0.126 0.432 3.50 9.73 19.96 48.24 98.59
Fluoroquinolones 120 0.033 0.070 0.27 0.56 1.51 4.39 14.01
Lincosamides 12 0.035 0.035 0.05 0.15 0.92 7.90 7.90
Pleuromutilins 8 0.185 0.185 1.46 2.72 4.12 31.95 31.95
Makrolides 97 0.013 0.064 0.64 1.42 4.45 31.12 76.22
Trimethoprim-sulfonamides 34 0.889 1.556 2.37 6.35 10.56 68.06 78.48
Fenicoles 16 0.019 0.019 0.16 0.75 2.08 12.72 12.72
Sulfonamides . . . . . . . .
weaner
Beta-lactams 135 0.003 0.081 0.74 2.20 5.44 19.42 64.68
Aminoglycosides 46 0.002 0.005 0.03 0.12 0.41 6.31 25.15
Cephalosporins 41 0.006 0.008 0.03 0.08 0.19 0.38 2.83
Tetracyclines 106 0.001 0.090 0.97 3.20 6.25 16.04 45.04
Polypeptides 103 0.011 0.463 2.07 5.14 9.26 21.39 68.66
Fluoroquinolones 60 0.003 0.008 0.03 0.10 0.26 1.52 2.63
Lincosamides 17 0.013 0.013 0.16 0.41 1.16 4.58 4.58
Pleuromutilins 10 0.009 0.009 0.44 1.35 2.06 3.13 3.13
Makrolides 73 0.004 0.009 0.08 0.31 1.36 14.16 23.67
Trimethoprim-sulfonamides 41 0.024 0.121 1.89 5.00 7.33 15.43 28.38
Fenicoles 17 0.000 0.000 0.03 0.08 0.25 1.57 1.57
Sulfonamides . . . . . . . .
fattening pig
Beta-lactams 260 0.004 0.009 0.07 0.81 3.09 8.74 16.88
Aminoglycosides 92 0.001 0.004 0.02 0.09 0.46 2.15 8.00
Cephalosporins 45 0.001 0.003 0.01 0.03 0.05 0.43 1.16
Tetracyclines 191 0.001 0.051 1.00 2.16 4.21 7.67 17.72
Polypeptides 62 0.004 0.161 0.66 1.78 4.06 12.90 16.57
(Continued)
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The finding of our recent study in general is in line with sales data for 2011 in Germany,
where penicillins were the antimicrobial class in second place as regards the sold amount. The
trend towards increasing use of beta-lactams and decreasing use of tetracyclines was already
discussed by Merle et al. [31]. Falling prices for beta-lactam antibiotics, as well as the compen-
sation for the loss of growth promoters were mentioned as reasons there.
In 2011 sales data on antimicrobial substances used in veterinary medicine in Germany
were collected obligatory for the first time. These data based on the announcements of pharma-
ceutical companies and wholesales, who sold drugs to veterinarians in Germany and were pub-
lished in context of the third ESVAC report [23,24], in which 25 European countries
are compared.
But, sales data is a total on suggested use in all animal species, which prohibited a direct
comparison for the data presented here for pigs only. In a recent publication we compared the
distribution of active ingredient classes for these sales data with the consumption data of our
study for all animal species under study, which are closely related. Taken into account that data
on turkey and other species was not available, an extrapolation from study data to sales data
was sufficient [32].
Jordan et al. [33] for Australia and Rajić et al. [34] for Canada asserted that the used
amounts of beta-lactams, tetracyclines and sulfonamides were the highest.
It is important to note that these are active ingredient classes, which are highly important
(tetracyclines and sulfonamides) or even critically important (beta-lactams) for human medi-
cine [35]. However, Morley et al. [36] defined exactly these active ingredient classes as
Table 4. (Continued)
active ingredient class Treatment frequency per 100 days
n min P5 P25 median P75 P95 max
Fluoroquinolones 154 0.003 0.008 0.03 0.07 0.18 0.68 8.75
Lincosamides 77 0.003 0.011 0.05 0.17 1.08 2.15 2.92
Pleuromutilins 45 0.002 0.006 0.46 1.13 2.39 5.44 11.67
Makrolides 159 0.002 0.005 0.04 0.25 1.52 5.30 25.48
Trimethoprim-sulfonamides 49 0.009 0.021 0.54 1.94 4.27 7.56 11.76
Fenicoles 57 0.001 0.005 0.02 0.04 0.12 0.77 3.80
Sulfonamides 1 . . . 0.71 . . .
doi:10.1371/journal.pone.0119114.t004
Table 5. Geometric means (GM) of the 100-day-treatment frequency of the ﬁxed inﬂuence factors for the four different age groups.
sow piglet weaner fattening pig
n GM Std n GM Std n GM Std n GM Std
region
northwest 75 0.62 6.7 76 9.87 5.48 72 3.78 6.88 168 2.29 8
middle 86 0.76 5.65 71 9.25 5.23 68 4.28 5.87 149 1.6 9.3
east 7 3.31 4.1 6 14.1 4.98 6 15.67 9 9 3.4 11.03
south 47 0.8 4.03 46 18.07 3.92 41 10.45 2.69 18 2.91 2.21
farm size
small 68 0.65 5.01 56 7.73 6.97 62 2.96 4.07 115 0.93 12.71
medium 63 0.63 5.85 60 13.65 3.86 60 4.55 6.8 113 2.24 5.53
large 84 0.96 6.01 83 12.5 4.65 65 9.93 5.59 116 3.85 5.7
doi:10.1371/journal.pone.0119114.t005
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Table 6. Final ANOVA for describing treatment frequencies (target variable: logarithmized 100-day- treatment frequency).
sow (R-Square: 0.326399)
source DF Sum of Squares Mean Square
Error 178 81.6707230 0.4588243
Correction Total 214 121.2449435
DF Type III SS Mean Square F Value Pr > F
region 2 1.34617447 0.67308724 2.64 0.1858
farm size 2 0.07275842 0.03637921 0.06 0.9459
veterinarian 13 19.42976993 1.49459769 3.26 0.0002
farm size*veterinarian 14 9.12067360 0.65147669 1.42 0.1478
region*veterinarian 4 1.01988934 0.25497233 0.56 0.6951
piglet (R-Square: 0.497702)
source DF Sum of Squares Mean Square
Error 163 49.26920456 0.30226506
Correction Total 198 98.08760267
DF Type III SS Mean Square F Value Pr > F
region 2 0.97108955 0.48554477 1.36 0.3793
farm size 2 2.72531103 1.36265551 1.46 0.2682
veterinarian 13 33.55440307 2.58110793 8.54 <.0001
farm size*veterinarian 13 12.14350519 0.93411578 3.09 0.0004
region*veterinarian 3 1.06889828 0.35629943 1.18 0.3196
weaner (R-Square: 0.453022)
source DF Sum of Squares Mean Square
Error 149 59.2655024 0.3977550
Correction Total 186 108.3508443
DF Type III SS Mean Square F Value Pr > F
region 2 1.16987186 0.58493593 7.69 0.0426
farm size 2 5.76430524 2.88215262 3,96 0.0415
veterinarian 13 18.64776524 1.43444348 3.61 <.0001
farm size*veterinarian 15 10.90852450 0.72723497 1.83 0.0355
region*veterinarian 4 0.30418793 0.07604698 0.19 0.9427
fattening pig (R-Square: 0.265086)
source DF Sum of Squares Mean Square
Error 298 212.2190436 0.7121444
Correction Total 343 288.7672195
DF Type III SS Mean Square F Value Pr > F
region 2 0.68633442 0.34316721 0.92 0.4557
farm size 2 2.83907983 1.41953991 1.11 0.3513
veterinarian 17 23.66596891 1.39211582 1.95 0.0139
farm size*veterinarian 18 23.03261344 1.27958964 1.80 0.0251
region*veterinarian 5 1.85830095 0.37166019 0.52 0.7597
doi:10.1371/journal.pone.0119114.t006
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antibiotics assigned to the “Primary Use Category” in veterinary medicine. It is constantly dis-
cussed, that the antibiotic use in food-producing animals might have a negative influence on
human health [2]. Nonetheless, Aarestrup et al. [37] cautioned about an increased risk to
human health if the antimicrobial consumption changes towards more critically important an-
timicrobials as a result of reduction measures. However, the broad spectrum and their relatively
low costs may be a reason for the high consumption quantities of these active ingredient clas-
ses. Furthermore, these substances mostly require high dosages, which lead to an associated
high consumption quantity.
Some authors also report, that these active ingredient classes were often used for metaphy-
lactic matters [38]. But for Germany this could not be improved by the means of our study de-
sign, which based on official forms only. Here, metaphylactic use was not reported as an
indication due to the general rules stated in the guidelines on the prudent use of antibiotics in
veterinary medicine [1].
In sows, tetracyclin, trimethoprim-sulfonamides and amoxicillin were mostly used in this
study. In piglets, amoxicillin, tetracyclin, trimethoprim-sulfonamides and colistin were
mostly used.
Dunlop et al. [28] show that especially gentamicin and penicillin were used in piglets, and
that in lactating sows especially penicillin was used. Beta-lactam antibiotics also play an impor-
tant role in this study. Jensen et al. [39] reported that beta-lactams seem to have the highest im-
portance in the treatment of piglets and sows over a period of time (2002–2008).
According to Dunlop et al. [28], tetracyclin and tylosin were only used to a very small extent
in piglets, but these substances were often used in fattening pigs [40]. In the meantime, these
substances seem to have gained in importance for treating piglets. According to Dunlop et al.
[28], tetracyclin was the second most used active ingredient in sows.
Also, in the study of Jensen et al. [39], tetracyclines were the fourth most used active ingredi-
ent in piglets and sows. Therefore, tetracyclines still have a quite high priority in the treatment
of piglets and sows.
Jensen et al. [39] reported that macrolide antibiotics, which implies the active ingredient
tylosin, have lost importance in the treatment of piglets and sows and have been replaced by
pleuromutilins. This could not be confirmed for piglets in our study; here, pleuromutilins only
played a minor role. Nevertheless, in sows, the amounts of used pleuromutilins and macrolides
were nearly the same.
Similar to this study, Dunlop et al. [28] and Jensen et al. [39] found out that potentiated sul-
fonamides are used extensively for treating piglets and sows. As well as tetracyclines, potentiat-
ed sulfonamides also seem to have a quite high priority in the treatment of piglets and sows.
In weaners, amoxicillin, tetracyclin, chlorotertacyclin as well as trimethoprim-sulfonamides
and colistin in almost equal quantities, were mostly applied in this study. In fattening pigs the
active ingredients amoxicillin, tylosin, chlorotetracyclin and tetracyclin were mostly used.
According to Dunlop et al. [28], already over a decade ago weaners and fattening pigs were
mostly treated with beta-lactams (here penicillin). In Australia, beta-lactams, tetracyclines and
sulfonamides are most commonly used [33]. In Spain and Belgium, macrolides, tetracyclines,
beta-lactams and polypeptides are mainly used in weaners and fattening pigs [38,41,42].
According to Callens et al. [26] the most commonly used active ingredient classes such as
potentiated sulfonamides and tetracyclines have remained the same in quantity over the years,
but the importance of individual active ingredient classes has shifted. Thus, modern antimicro-
bials (e.g. cephalosporins) are increasingly used, because they promise advantages to the farmer
relating to their long and potent acting [26]. In addition, these substances have to be adminis-
tered in lower doses and less frequently, whereby they are of no importance regarding quanti-
ties used. To be able to evaluate the importance concerning the actual use of these substances,
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and the shift from the use of substances of low importance in human medicine to substances of
high importance for medicine, it is essential to collect detailed data on each antimicrobial used
and to describe the individual usage patterns by use of appropriate terms [21,25,26].
98% of the used quantity was administered orally, whereas in this connection especially
treatments of weaners and fattening pigs led to this distribution. This observation corresponds
with the in ESVAC reported high amounts of oral powder of antibiotic substances [23]. Merle
et al. [13] also reported that 97% of the amount used in pigs was administered orally. Also Tim-
merman et al. [38] showed this distribution between oral and parenteral administered quanti-
ties in pigs, where group treatments were also conducted for reasons of metaphylaxis especially
in weaners and fattening pigs. In this context, higher quantities of antimicrobial substances
had to be used compared to parenteral single treatments because, on the one hand, orally ad-
ministered substances have to be dispensed at higher doses, and, on the other hand, higher
quantities are needed for treating a high number of animals at the same time. This also clearly
shows that the consideration of pure quantities may lead to a distorted picture.
5. Indication for treatment
Among all age groups, respiratory diseases represent the main indication for the use of antimi-
crobials. It should be stressed here again that in Germany prophylactic usage of antibiotics is
not allowed. The evaluation of reasons for using antimicrobial substances based on the docu-
mentation on official forms, on which any treatment administered to the animal is documented
obligatory by the veterinarian. Therefore, the documentation and report of misuse, off-label
use and prophylactic use is not possible with this study design.
Respiratory diseases are primarily treated with beta-lactam antibiotics in piglets, weaners
and fattening pigs, but not in sows. Except for sows, intestinal diseases are the next most fre-
quent indication for antibiotic treatment. In our study, mainly macrolides (tylosin) and poly-
peptides (colistin) are used for treating intestinal diseases. Chauvin et al. [20] also reported that
respiratory and intestinal diseases are the most common indications for antibiotic treatment.
Here, colistin and tylosin were also most commonly used against intestinal diseases, but against
respiratory diseases mainly tetracyclines were used. Casal et al. [41] also reported that colistin
was mainly used for treating intestinal disease, even with a high prophylactic use, i.e. without
defined diagnosis. Casal et al. [41] also reported that respiratory diseases were also treated
mainly with tetracyclines, with beta-lactams being only the second most used active ingredient
and that prophylactic treatments play an important role again. Jensen et al. [39] commented
that intestinal diseases constitute the main indication, which is treated with macrolides and tet-
racyclines to a large extent. However, especially in fattening pigs, also pleuromutilins are used
in one third for that indication. In this study, respiratory diseases are listed as the second most
common indication, especially tetracyclines playing the main role in their treatment, beta-lac-
tams making up only a small percentage. In another study, intestinal diseases also seem to rep-
resent the main indication [38]. The increase in prescriptions against intestinal diseases and
the associated decrease of prescriptions of drugs against respiratory diseases was reported by
Arnold et al. [25]. In contrast, Jensen et al. [39] reported rather an increase in the treatment of
respiratory diseases, and a decrease in the treatment of intestinal diseases.
The second most common indication for sows is diseases of the reproductive organs, which
are primarily treated with tetracyclines. According to Chauvin et al. [20], tetracyclines were rarely
used for treatment of reproductive organ diseases. Here, in particular sulfonamides, fluoroquino-
lones and beta-lactams played a role. A similar picture is also described by Jensen et al. [39].
Considering seasonal effects in view of antimicrobial consumption might give an allusion to
seasonal dependencies on disease patterns. However, it must be emphasized that different
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consumption levels by season may be caused by differences in the number of animals kept in
the individual time periods. This could not be answered with our data due to the documenta-
tion of average numbers of animals kept over one year only.
Thus, the highest drug use in piglets was detected in autumn in our study. In autumn,
amoxicillin was used in highest quantities. Furthermore, amoxicillin was used for treating re-
spiratory diseases, which was the main indication for treating piglets in our study. Based on
these results, it could be speculated that there was an increase in respiratory diseases due to fall-
ing temperatures in autumn and the associated higher susceptibility to infections in younger
animals. Nevertheless, this could not be confirmed for weaners and fattening pigs; there the
hightest amount of antimicrobials usually consumed for treating respiratory diseases was in
winter and spring. In contrast to theses observations, recently, Sanchez-Vazquez et al. [43] de-
scribed that pulmonal lesions were observed most frequently in slaughtered pigs during No-
vember and December.
As regards colistin and tylosin, the antimicrobials commonly used for treating intestinal dis-
orders, again there was no consistent picture. Low amounts were used in winter for piglets and
fattening pigs, but not for weaners. As regards weaners and fattening pigs, quite high amounts
were used in spring to treat dysenteriae.
When looking at sows, the highest drug use in our study was detected in spring, with the
highest amounts of tetracycline used in spring. In addition, tetracycline is mainly used for
treating respiratory diseases and diseases of the reproductive organs, which were at the top of
the indications in sows in our study. However, sows are continuously used throughout the year
for producing piglets, so that a seasonal accumulation of diseases of the reproductive organs
could be ruled out.
In the feasibility study, no seasonal effects were observed with regard to used quantities in
all age groups covered in the study [44], but looking at antimicrobial consumption in pigs in a
certain rural district, more than half of the amounts were used in summer [45]. In the other
seasons only one quarter of this amount was consumed. However, the number of treated ani-
mals was the highest here in summer, in fact even more than twice as high than in
other seasons.
6. Frequency of antimicrobial drug use
In our study, the highest median treatment frequency—for a standardized period of 100 days—
was calculated for piglets with 14.7 days, followed by weaners with 6.6 days, and fattening pigs
with 3.7 days. The lowest rate was calculated for sows with median 0.9 days per 100 days. In the
previous feasibility study, arithmetic means had been reported. There, the treatment frequency
for piglets was lower with 6.1 days per 100 days, but at the same magnitude for sows with a treat-
ment frequency of 0.9 days per 100 days. For fattening pigs, the average treatment frequency,
which was observed in the feasibility study, was higher with 4.6 days per 100 days on average
[31] compared to this study. In an antibiotic usage monitoring study, which was undertaken in
Lower Saxony, a region in the North of Germany, in 2011, a treatment frequency of 4.6 days
within the period of a fattening passage (115 days) for fattening pigs was calculated on average
[46]. Converted to 100 days, this would result in a treatment frequency of 4.0 days and thus in
the same order of magnitude.
In summary, while the treatment frequencies of sows and fattening pigs calculated in these
three studies are similar to each other, the treatment frequency of piglets is more than twice as
high in our study than in the feasibility study. This could be explained by a misclassification of
weaners and piglets, which may have had impact on the results, because data is from veterinary
practitioners, who were note standardized in beforehand. In this case, treatment frequency for
Antibiotic Usage in Pigs in Germany
PLOS ONE | DOI:10.1371/journal.pone.0119114 March 18, 2015 22 / 28
piglets may have been overestimated and the treatment frequency of piglets may have been less
than the calculated value, while the actual treatment frequency of weaners was possibly much
higher than the calculated median value.
Merle et al. [31] already compared the results of the feasibility study with those of other Eu-
ropean member states with a more or less similar farming structure. As described above, most
consumption data based on amounts and uses theoretical DDDA for estimating the antibiotics
usage. Our data based on UDDA, a fact that does not allow a direct comparison. Merle et al.
[47] constituted the differences between UDD and ADD in detail. However, most important is
that nUDDA uses the number of treated animals as well as the applied dosage directly without
any estimation. This may reduce the variance of the given information. In addition, veterinari-
ans choice of dosage is linked to the situation indicated within the farm, which avoid bias due
to the accounting via DDDA. This has to be taken into account comparing our data with results
of other studies.
Bos et al. [24] calculated the ADDD/year for fattening pigs and sow—piglet- units in the
Netherlands for 2011. For fattening pigs a median ADDD/year of 3.0 was reported, which im-
plies 3 days of treatment per fattening pig within one year in the Netherlands. Thus, the actual
treatment frequency of fattening pigs in Germany is higher than the estimated treatment fre-
quency in the Netherlands. For sow-piglet-units a median ADDD/year of 9.3 was calculated.
This is difficult to compare to our detailed results for piglets and sows, but the Dutch estimated
treatment frequency of sows and piglets also seem to be lower than the German actual treat-
ment frequencies for sows and piglets.
Looking at the treatment frequencies concerning individual active ingredient classes, beta-
lactams represent the active ingredient class that was used on most farms among all age groups,
with a treatment frequency of 4.3 days for piglets, 0.2 days for sows, 2.2 days for weaners and
0.8 days for fattening pigs, respectively. In contrast, Vieira et al. [27] noted the highest treat-
ment incidence rates within 100 pig-days under risk for tetracyclines (0.7 ADD/100 pig-days
under risk) and macrolides (0.44 ADD/100 pig-days under risk) for fattening pigs in Denmark.
Bos et al. [24] calculated an ADDD/year per active ingredient class and animal group for farms
in the Netherlands. Here, also for tetracyclines the highest values were evaluated both in fatten-
ing pigs and in sow—piglet—units. In second place and third place beta-lactams and trimetho-
prim-sulfonamides were shown for Dutch fattening pigs.
However, in the feasibility study Merle et al. [13] determined that looking at treatment fre-
quencies concerning individual active ingredient classes, trimethoprim-sulfonamides is by far
the most commonly used in piglets, sows and fattening pigs. In the feasibility study, in piglets
trimethoprim-sulfonamides was applied 9.6 days (arithmetic mean) per 100 days, in sows
0.3 days (median) per 100 days and in fattening pigs 3.8 days (arithmetic mean) per 100 days,
respectively. In our study, trimethoprim-sulfonamides was only used in 36% of all sow keeping
farms, in 17% of all piglet keeping farms and in 14% of all farms keeping fattening pigs. Within
these farms, trimethoprim-sulfonamides was applied to piglets at 6.4 days, to sows at 0.3 days
and to fattening pigs at about two days over a period of 100 days.
As another example, on all farms which used polypeptides for treating infections, piglets
were treated 9.7 days (median) per 100 days with polypeptides. Here, especially colistin plays
the major role. Polypeptides are used for the treatment of respiratory infections as well as intes-
tinal infections [48], which constitutes the two most common reasons for treating piglets.
Chauvin et al. [20] reported that polypeptides are used almost exclusively against intestinal dis-
eases. Timmerman et al. [38] calculated a treatment incidence for colistin in fattening pigs
(TIUDDpig: 32.8), which is in third place compared to other active substances. The fact that the
treatment incidence is not directly identical with the treatment frequency and that other
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authors [27,39] do not report information on polypeptides, leads to difficulties in a
direct comparison.
As polypeptides are quite lowly dosed compared to sulfonamides and tetracyclines, which
are mainly used against intestinal and respiratory diseases, according to Jensen et al. [39], poly-
peptides only play a minor role regarding quantities used. Therefore, the actual importance of
this substance is shown by looking at the individual treatments only. Once again, this under-
lines the advantage of treatment frequency.
Vieira et al. [27] noted that there is a significantly higher treatment frequency on small
farms keeping fattening pigs than on larger farms. This was justified by the higher entry of
pathogens based on worse hygiene management on smaller farms (animal keeping as a hobby).
In contrast, van der Fels-Klerx et al. [29] determined that the treatment frequencies on large
farms keeping sows and fattening pigs is higher than on smaller farms. This is explained with a
higher level of exposure of animals to infective agents on large farms. In our study the influence
of the factors "farm size", "region" and "veterinarian", as well as their interaction, on the treat-
ment frequency were studied with an analysis of variance model. Here, the farm size on its own
seemed to have no influence on the treatment frequency, except a slight influence on the treat-
ment frequency of weaners.
Considering the treatment frequency within the age groups it becomes obvious that piglets
are far the most commonly treated age group, followed by weaners and fattening pigs. In con-
trast, sows are treated rarely. In addition, the model has shown that in this study the farm size
only had a significant influence on the treatment frequency in interaction with the veterinarian.
This could be justified due to the fact that several veterinarians advise farms of different sizes
and that they follow different treatment strategies. Furthermore, the veterinarian alone has a
significant impact on the treatment frequency. This may also be justified with different speciali-
zations of the different veterinarians. Thus, some veterinarians are specialized in the supervi-
sion of fattening pigs, whereas others are specialized in the supervision of sows and piglets,
whereby here also different treatment strategies are followed.
Callens et al. [26] also observed that 90% of the treatments take place during the first 10
weeks of life, whereas fattening pigs are treated rarely. These results differ from those of Dun-
lop et al. [28], who determined that most of the individual treatments were given to piglets
and sows at parturition, fattening pigs being treated scarcely and weaners being treated very
rarely. Here, the low frequencies of treatment in weaners and fattening pigs are explained by
good farm and hygiene management of the corresponding farms. Jensen et al. [39] determined
that younger animals are treated more often than older animals (weaners more often than fat-
tening pigs). Here, the frequency of treatment in piglets and sows cannot be interpreted be-
cause they were not considered individually, but as a unit. A higher treatment frequency of
younger animals may be due to a higher susceptibility to infection. Especially on farms keep-
ing weaners, which include animals from different origins as well as on farms with a high ani-
mal movement, a high infection pressure and the resulting greater need for treatment could
exist [29,42].
The invariably right-skewed distribution of the treatment frequencies shows for all age
groups the majority of farms having rather low and only a few farms having higher treatment
frequencies. This observation is also documented by Bos et al. [24] for the antibiotic usage on
farm level in the Netherlands. Jordan et al. [33] observed a distribution with normally distribut-
ed antimicrobial use indices for pig farms in Australia. Here, a moderate antimicrobial use
index was determined for the majority of farms, but there were a few farms with low or high
antimicrobial use indices in equal shares.
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Conclusion
In Germany a representative scientific collection of data on the antibiotic use in food-producing
animals is feasible. The legally binding requirement to document all treatments and deliveries
provides an excellent data source, allowing for a penetrative analysis at an individual animal
level. Therefore, conclusions about the actual usage of antibiotics are allowed, both on the level
on amounts of drugs as well as on the level of number of used daily doses (per antibiotic class).
In total amounts, tetracyclines, beta-lactams and trimethoprim-sulfonamides are the most
commonly used active ingredient classes in pigs in Germany. This general observation does
not differ from the results of other antibiotic consumption studies in other countries. However,
if data is stratified in the different age-classes of pig's life, the using pattern changes and beta-
lactams, macrolides and also polypeptides seem to have become more important in treating
pigs in Germany.
In the VetCAb study, the median treatment frequency—for a standardized period of 100
days—was calculated for piglets with 14.7 days. Weaners are treated at 6.6 days, and fattening
pigs at 3.7 days. The lowest rate was calculated for sows with median 0.9 days per 100 days.
These treatment frequencies only differ little from the treatment frequencies calculated in earli-
er antibiotic consumption studies, which were carried out in Germany.
Most consumption data based on amounts and uses theoretical DDDA for estimating the
antibiotics usage. The data used in the VetCAb study based on UDDA, a fact that does not
allow a direct comparison. However, most important is that nUDDA uses the number of treat-
ed animals as well as the applied dosage directly without any estimation. This may reduce the
variance of the given information. Thus, actual treatment frequencies possibly differ from esti-
mated treatment frequencies.
The data shows, that same antimicrobial substances both in human and veterinary medicine
are used, which may cause a development and a transfer of resistance. But, linking the data col-
lected in our study with human health is not allowed due to a lack of similar information for
human treatment.
Our study is the first cross-sectional study on antimicrobial usage in pig farming in entire
Germany. As a first reference point our data may be used to develop rules for regular or elevat-
ed use of antibiotic substances of German farming practice to describe the situation. However,
without accompanying studies on the resistance level in livestock in Germany, it remains diffi-
cult to realize comparative observations on the two research sectors.
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